Last viewed:
NTRA
Prices are updated after-hours
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
(0.0% 1d)
(-0.4% 1m)
(79.6% 1y)
(0.0% 2d)
(2.7% 3d)
(6.8% 7d)
(5.13%
volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 11,045,723,009
http://www.natera.com
Sec
Filling
|
Patents
| 1039 employees
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.
genetic
diagnostics
add to watch list
Paper trade
email alert is off
Press-releases
Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications
Published: 2024-04-22
(Crawled : 14:00)
- biospace.com/
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
| 6.75%
| O: 1.38%
H: 3.26%
C: 2.49%
milestone
Liberty All-Star® Growth Fund, Inc. March 2024 Monthly Update
Published: 2024-04-12
(Crawled : 00:20)
- prnewswire.com
AMZN
S
|
$176.57
-1.65%
-3.18%
32M
|
Retail Trade
| Email alert
Add to watchlist
CWST
|
$94.98
-0.47%
-0.47%
190K
|
Industrial Services
| Email alert
Add to watchlist
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
| Email alert
Add to watchlist
PGNY
|
$32.6
0.62%
0.61%
760K
|
Commercial Services
| Email alert
Add to watchlist
SPSC
|
$171.005
0.24%
-0.75%
190K
|
Technology Services
| Email alert
Add to watchlist
TRNS
|
$111.31
-3.19%
-3.3%
34K
|
Electronic Technology
| Email alert
Add to watchlist
VERX
|
News
0
d
|
$28.89
3.4%
3.29%
5.6M
|
Technology Services
| Email alert
Add to watchlist
CR
|
$142.13
2.91%
0.01%
440K
|
Producer Manufacturing
| Email alert
Add to watchlist
EME
|
$338.89
0.24%
0.0%
500K
|
Industrial Services
| Email alert
Add to watchlist
SITE
|
$163.76
0.68%
1.93%
250K
|
Distribution Services
| Email alert
Add to watchlist
star
update
liberty
growth
Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
Published: 2024-04-11
(Crawled : 00:00)
- biospace.com/
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
| -5.66%
| O: -0.36%
H: 0.0%
C: 0.0%
kidney
publication
study
Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Published: 2024-04-08
(Crawled : 13:30)
- biospace.com/
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
| -5.9%
| O: 0.92%
H: 0.26%
C: -2.26%
test
for
heart
Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
Published: 2024-04-05
(Crawled : 12:30)
- biospace.com/
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
| -1.75%
| O: 2.12%
H: 4.35%
C: 2.25%
bladder
positive
cancer
trial
Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
Published: 2024-04-01
(Crawled : 17:00)
- biospace.com/
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
| -0.46%
| O: -0.6%
H: 2.8%
C: 2.25%
cancer
trials
trial
Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer
Published: 2024-03-18
(Crawled : 12:30)
- biospace.com/
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
| 1.7%
| O: 0.19%
H: 1.46%
C: 0.48%
cancer
trial
Natera to Present New Data at the 2024 SGO Annual Meeting on Women’s Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast Cancers
Published: 2024-03-12
(Crawled : 17:00)
- biospace.com/
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
| 1.97%
| O: 0.07%
H: 1.68%
C: 1.65%
breast
meeting
Natera to Participate in March Investor Conferences
Published: 2024-02-29
(Crawled : 16:00)
- biospace.com/
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
| 18.93%
| O: 11.99%
H: 5.68%
C: 0.89%
Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call
Published: 2024-02-20
(Crawled : 14:00)
- biospace.com/
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
| 30.04%
| O: -1.86%
H: 2.81%
C: 2.47%
conference
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001415889-24-011407
4
2024-04-24
2024-04-21
Sell
M
143
430
0001415889-24-011407
4
2024-04-24
2024-04-20
Sell
M
190
1332
0001415889-24-011407
4
2024-04-24
2024-04-21
Buy
M
143
321364
0001415889-24-011407
4
2024-04-24
2024-04-20
Buy
M
190
321221
0001415889-24-011406
4
2024-04-24
2024-04-21
Sell
M
644
1932
0001415889-24-011406
4
2024-04-24
2024-04-20
Sell
M
856
5992
0001415889-24-011406
4
2024-04-24
2024-04-23
Sell
S
787
205552
0001415889-24-011406
4
2024-04-24
2024-04-21
Buy
M
644
206339
0001415889-24-011406
4
2024-04-24
2024-04-20
Buy
M
856
205695
0001415889-24-011405
4
2024-04-24
2024-04-23
Sell
S
531
117029
0001415889-24-011404
4
2024-04-24
2024-04-23
Sell
S
522
111677
0001415889-24-011403
4
2024-04-24
2024-04-21
Sell
M
1775
5324
0001415889-24-011403
4
2024-04-24
2024-04-20
Sell
M
3386
23702
0001415889-24-011403
4
2024-04-24
2024-04-23
Sell
S
2552
230319
0001415889-24-011403
4
2024-04-24
2024-04-21
Buy
M
1775
232871
0001415889-24-011403
4
2024-04-24
2024-04-20
Buy
M
3386
231096